BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 19609323)

  • 1. Structural basis for recruitment of BRCA2 by PALB2.
    Oliver AW; Swift S; Lord CJ; Ashworth A; Pearl LH
    EMBO Rep; 2009 Sep; 10(9):990-6. PubMed ID: 19609323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.
    Park JY; Singh TR; Nassar N; Zhang F; Freund M; Hanenberg H; Meetei AR; Andreassen PR
    Oncogene; 2014 Oct; 33(40):4803-12. PubMed ID: 24141787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasticity of BRCA2 function in homologous recombination: genetic interactions of the PALB2 and DNA binding domains.
    Siaud N; Barbera MA; Egashira A; Lam I; Christ N; Schlacher K; Xia B; Jasin M
    PLoS Genet; 2011 Dec; 7(12):e1002409. PubMed ID: 22194698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.
    Zhang F; Fan Q; Ren K; Andreassen PR
    Mol Cancer Res; 2009 Jul; 7(7):1110-8. PubMed ID: 19584259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PALB2 regulates recombinational repair through chromatin association and oligomerization.
    Sy SM; Huen MS; Zhu Y; Chen J
    J Biol Chem; 2009 Jul; 284(27):18302-10. PubMed ID: 19423707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PALB2 is an integral component of the BRCA complex required for homologous recombination repair.
    Sy SM; Huen MS; Chen J
    Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7155-60. PubMed ID: 19369211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
    Zhang F; Ma J; Wu J; Ye L; Cai H; Xia B; Yu X
    Curr Biol; 2009 Mar; 19(6):524-9. PubMed ID: 19268590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2.
    Hartford SA; Chittela R; Ding X; Vyas A; Martin B; Burkett S; Haines DC; Southon E; Tessarollo L; Sharan SK
    PLoS Genet; 2016 Aug; 12(8):e1006236. PubMed ID: 27490902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanism for the suppression of homologous recombination in G1 cells.
    Orthwein A; Noordermeer SM; Wilson MD; Landry S; Enchev RI; Sherker A; Munro M; Pinder J; Salsman J; Dellaire G; Xia B; Peter M; Durocher D
    Nature; 2015 Dec; 528(7582):422-6. PubMed ID: 26649820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination.
    Buisson R; Dion-Côté AM; Coulombe Y; Launay H; Cai H; Stasiak AZ; Stasiak A; Xia B; Masson JY
    Nat Struct Mol Biol; 2010 Oct; 17(10):1247-54. PubMed ID: 20871615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2.
    Dray E; Etchin J; Wiese C; Saro D; Williams GJ; Hammel M; Yu X; Galkin VE; Liu D; Tsai MS; Sy SM; Schild D; Egelman E; Chen J; Sung P
    Nat Struct Mol Biol; 2010 Oct; 17(10):1255-9. PubMed ID: 20871616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
    Bowman-Colin C; Xia B; Bunting S; Klijn C; Drost R; Bouwman P; Fineman L; Chen X; Culhane AC; Cai H; Rodig SJ; Bronson RT; Jonkers J; Nussenzweig A; Kanellopoulou C; Livingston DM
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8632-7. PubMed ID: 23657012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated in silico approach to analyze the involvement of single amino acid polymorphisms in FANCD1/BRCA2-PALB2 and FANCD1/BRCA2-RAD51 complex.
    Doss CG; Nagasundaram N
    Cell Biochem Biophys; 2014 Nov; 70(2):939-56. PubMed ID: 24817641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.
    Xia B; Sheng Q; Nakanishi K; Ohashi A; Wu J; Christ N; Liu X; Jasin M; Couch FJ; Livingston DM
    Mol Cell; 2006 Jun; 22(6):719-729. PubMed ID: 16793542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.
    Biswas K; Das R; Eggington JM; Qiao H; North SL; Stauffer S; Burkett SS; Martin BK; Southon E; Sizemore SC; Pruss D; Bowles KR; Roa BB; Hunter N; Tessarollo L; Wenstrup RJ; Byrd RA; Sharan SK
    Hum Mol Genet; 2012 Sep; 21(18):3993-4006. PubMed ID: 22678057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compensatory functions and interdependency of the DNA-binding domain of BRCA2 with the BRCA1-PALB2-BRCA2 complex.
    Al Abo M; Dejsuphong D; Hirota K; Yonetani Y; Yamazoe M; Kurumizaka H; Takeda S
    Cancer Res; 2014 Feb; 74(3):797-807. PubMed ID: 24285729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PALB2: the hub of a network of tumor suppressors involved in DNA damage responses.
    Park JY; Zhang F; Andreassen PR
    Biochim Biophys Acta; 2014 Aug; 1846(1):263-75. PubMed ID: 24998779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance.
    Menzel T; Nähse-Kumpf V; Kousholt AN; Klein DK; Lund-Andersen C; Lees M; Johansen JV; Syljuåsen RG; Sørensen CS
    EMBO Rep; 2011 Jul; 12(7):705-12. PubMed ID: 21637299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of PALB2 as a candidate melanoma susceptibility gene.
    Aoude LG; Xu M; Zhao ZZ; Kovacs M; Palmer JM; Johansson P; Symmons J; Trent JM; Martin NG; Montgomery GW; Brown KM; Hayward NK
    PLoS One; 2014; 9(6):e100683. PubMed ID: 24949998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PALB2 self-interaction controls homologous recombination.
    Buisson R; Masson JY
    Nucleic Acids Res; 2012 Nov; 40(20):10312-23. PubMed ID: 22941656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.